Recent Updates
-
*NQF 0004 (Additional): Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (a) Initiation, (b) Engagement
<p>Measure: NQF 0004 (Additional Measure)</p> <p>Measure Title: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement</p> <p>Measure Description: The percentage of adolescent and adult patients with a new episode of alcohol and other drug (A... -
NQF 0032 (Additional): Cervical Cancer Screening
<p>Measure: NQF 0032 (Additional Measure)</p> <p>Measure Title: Cervical Cancer Screening </p> <p>Measure Description: Percentage of women 21-64 years of age, whom received one or more Pap tests to screen for cervical cancer. </p> <p>*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL QM MEASURE: Cli... -
NQF 0075 (Additional): Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
<p>Measure: NQF 0075 (Additional Measure)</p> <p>Measure Title: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</p> <p>Measurement Description: The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary a... -
NQF 0055 (Additional) Diabetes: Eye Exam
<p>Measure: NQF 0055 (Additional Measure)</p> <p>Measure Title: Diabetes: Eye Exam</p> <p>Measure Description: The percentage of patients 18–75 years of age with Diabetes (Type 1 or Type 2) whom had a retinal or dilated eye exam or a negative retinal exam (no evidence of retinopathy) by an e... -
NQF 0012 (Additional): Prenatal Care - Screening for Human Immunodeficiency Virus (HIV)
<p>Measure: NQF 0012 (Additional Measure)</p> <p>Measure Title: Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)</p> <p>Measure Description: Percentage of patients, regardless of age, who gave birth during a 12-month period who were screened for HIV infection during the first... -
(DRAFT) *NQF 0033 (Additional): Chlamydia Screening for Women age 15-24
<p>Measure: NQF 0033 (Additional Measure) </p> <p>Measure Title: Chlamydia Screening for women</p> <p>Measure Description: Percentage of women 15-24 years of age whom were identified as sexually active and whom had at least one test for chlamydia during the reporting period. </p> <p>*REQUIRED ... -
NQF 0575 (Additional): Diabetes: Hemoglobin A1c Control (<8.0%)
Measure: NQF 00575 (Additional Measurement)
Measure Title: Diabetes: HbA1c Control (<8%)
Measure Description: The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) whom had HbA1c <8.0%.
-
NQF 0001 - (Additional) Asthma Assessment
<p>Measure: NQF 0001 (Additional Measure) </p> <p>Measure Title: Asthma Assessment</p> <p>Measure Description: Percentage of patients aged 5 through 40 years with a diagnosis of asthma and who have been seen for at least 2 office visits, who were evaluated during at least one office visit wit... -
NQF 0387 - (Additional) Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen
<p>Measure: NQF 0387 (Additional Measurement)</p> <p>Measure Title: Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen </p> <p>Measure Description: Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Canc... -
NQF 0002 - (Additional) Appropriate Testing for Children with Pharyngitis
<p>Measure: NQF 0002 (Additional Measure)</p> <p>Measure Title: Appropriate Testing for Children with Pharyngitis</p> <p>Measure Description: The percentage of children 2–18 years of age who were diagnosed with Pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) t...